Group One Trading
NAUT icon

Group One Trading’s Nautilus Biotechnolgy NAUT Stock Holding History

Group One Trading’s Portfolio NAUT Stock Details NAUT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$49.2K Buy
+26,300
New +$69.4K ﹤0.01% 5417
2023
Q3 		– Sell
-33,800
Closed -$131K – 8055
2023
Q2 		$131K Sell
33,800
-211,900
-86% -$610K ﹤0.01% 4349
2023
Q1 		$681K Buy
+245,700
New +$515K ﹤0.01% 2475
2022
Q2 		– Sell
-1,700
Closed -$7K – 8262
2022
Q1 		$7K Sell
1,700
-2,100
-55% -$8.62K ﹤0.01% 7302
2021
Q4 		$20K Sell
3,800
-3,700
-49% -$19.8K ﹤0.01% 6984
2021
Q3 		$46K Buy
+7,500
New +$59.8K ﹤0.01% 6604

Other funds holding NAUT

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
ACM
AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return
CM
Cercano Management Bellevue, Washington $750M AUM 25.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CFM
Comprehensive Financial Management Los Gatos, California $3.05B AUM 1.77% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
CA
Clearstead Advisors Cleveland, Ohio $10.6B AUM 24.87% 1-Year Est. Return

Group One Trading's NAUT Position: Q2 2026 in Review

Group One Trading opened a new position in Nautilus Biotechnolgy (NAUT) in Q2 2026: 8,197 shares worth $15.3K. The stake represents ﹤0.01% of the portfolio and ranks #6166 among its holdings. This is a return to the name: Group One Trading previously reported a position in NAUT as recently as Q4 2025.

Group One Trading first reported a position in NAUT in Q3 2021 and has held it in 6 quarters since. The position peaked at $415K in Q1 2023. 93 funds tracked by Wall St. Rank hold NAUT as of Q2 2026.

  • Group One Trading held 8,197 shares of Nautilus Biotechnolgy worth $15.3K as of Q2 2026.
  • Nautilus Biotechnolgy was a new Group One Trading position in Q2 2026.
  • Nautilus Biotechnolgy made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #6166 holding.
  • Group One Trading first reported a position in Nautilus Biotechnolgy in Q3 2021 and has held it in 6 quarters since.
  • Group One Trading's Nautilus Biotechnolgy position peaked at $415K in Q1 2023.
  • 93 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.